HALO logo
halo search icon
Quince Therapeutics, Inc.

US$1.07

Price Change Indicator
-0.01 (-0.926%)
Quince Therapeutics, Inc.
QNCX · NAS

Quince Therapeutics, Inc.

Start Trading QNCX for Free

US$1.07

Price Arrow-0.01 (-0.926%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BearishEngulfing Bearish (Realtime)HALO AllHALO Consensus ValueHALO Earnings Momentum+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Quince Therapeutics, Inc. Overview

QNCX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About QNCX

icon
icon

Telephone

1.650.910.5717

icon

Address

Suite 273, 611 Gateway Boulevard, South San Francisco, CA 94080

Description

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

QNCX Price Chart

Key Stats

Market Cap

US$17.60M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.79 - 45.5

Trade Value (12mth)

US$2,252,692.00

1 week

-6.09%

1 month

-21.17%

YTD

-96.4%

1 year

-90.09%

All time high

1219.80

Key Fundamentals

EPS 3 yr Growth

8.70%

EBITDA Margin

0.00%

Operating Cashflow

-$41m

Free Cash Flow Return

-874.20%

ROIC

NaN%

Interest Coverage

0.00

Quick Ratio

0.50

Other Data

Shares Outstanding (Fully Diluted)

9m

HALO Sector

Healthcare

Next Company Report Date

23-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

QNCX Announcements

Latest Announcements

DateAnnouncements
22 May 26
22 May 26
19 May 26
18 May 26
18 May 26

QNCX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-8.43-13.14-16.76locklocklock
EPS (Fully Diluted)
 $locklocklocklock-8.43-13.14-16.76locklocklock
Growth
 %locklocklocklock45.3-55.9-27.6locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Quince Therapeutics, Inc. (QNCX:NAS)?
Halo FAQ
The current share price of Quince Therapeutics, Inc. (QNCX:NAS) is USD$1.07.
What is the 52-week high share price for Quince Therapeutics, Inc. (QNCX:NAS)?
Halo FAQ
The 52-week high share price for Quince Therapeutics, Inc. (QNCX:NAS) is USD$45.50.
What is the 52-week low share price for Quince Therapeutics, Inc. (QNCX:NAS)?
Halo FAQ
The 52-week low share price for Quince Therapeutics, Inc. (QNCX:NAS) is USD$0.79.
What is the dividend yield for Quince Therapeutics, Inc. (QNCX:NAS)?
Halo FAQ
Quince Therapeutics, Inc. (QNCX:NAS) does not pay a dividend.
What was Quince Therapeutics, Inc. (QNCX:NAS) last dividend payment?
Halo FAQ
Quince Therapeutics, Inc. (QNCX:NAS) does not pay a dividend.
What is the franking level for Quince Therapeutics, Inc. (QNCX:NAS)?
Halo FAQ
Quince Therapeutics, Inc. (QNCX:NAS) has a franking level of 0.00%.
In which sector is Quince Therapeutics, Inc. (QNCX:NAS) classified?
Halo FAQ
Quince Therapeutics, Inc. (QNCX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial